• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IRHYTHM TECHNOLOGIES, INC ZIO AT; DETECTOR AND ALARM, ARRHYTHMIA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IRHYTHM TECHNOLOGIES, INC ZIO AT; DETECTOR AND ALARM, ARRHYTHMIA Back to Search Results
Device Problem Failure to Transmit Record (1521)
Patient Problem Unspecified Heart Problem (4454)
Event Date 06/12/2022
Event Type  malfunction  
Manufacturer Narrative
The hcp account was notified on day 9 that the device had met the asymptomatic transmission limit, and a replacement device zio at patch and gateway was shipped.Irhythm became aware of the arrhythmia while preparing final report and notified the hcp on day 20.When a patient is approaching the limit for either transmission type, irhythm reaches out to the clinician to inform the clinician that a replacement zio at patch and gateway will be sent, unless a clinician representative determines a replacement is not needed.In keeping with fda¿s position on reporting expectations as communicated to the company in may 2023, irhythm aligned to a reporting approach for mdns that were not communicated during the wear period due to a maximum transmission limit being reach, and agreed to treat these instances as malfunction mdrs for reporting purposes.This report does not constitute an admission by irhythm that the product described in this report has any defects or has malfunctioned.Certain terms included in form fda 3500a and related mdr submission materials are fixed terms for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.
 
Event Description
No adverse events, such as death or serious injury, are known to have occurred.The patient experienced an arrhythmia that met the criteria for medical doctor notification (mdn) (arrhythmias of clinical interest during the product wear period) for the hcp location, but that was not conveyed to the hcp location during the wear period.The investigation confirmed that the zio at reached the asymptomatic maximum transmission limit for the zio at device, prompting a contact to the hcp account.Also, under the process in place at the time of this event, when a transmission limit had been reached, the zio at daily report would reflect that to the hcp account through ¿trigger off¿ icons.The hcp was notified that the device had met the asymptomatic transmission limit, and a replacement device was sent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZIO AT
Type of Device
DETECTOR AND ALARM, ARRHYTHMIA
Manufacturer (Section D)
IRHYTHM TECHNOLOGIES, INC
699 8th st suite 600
san francisco CA 94103
Manufacturer (Section G)
IRHYTHM TECHNOLOGIES, INC
6550 katella avenue, suite 200
cypress CA 90630
Manufacturer Contact
mazi kiani
699 8th st suite 600
san francisco, CA 94103
9494132147
MDR Report Key17831168
MDR Text Key324458131
Report Number3007208829-2023-00077
Device Sequence Number1
Product Code DSI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K163512
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 09/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/28/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date09/18/2022
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/18/2022
Date Manufacturer Received06/21/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age77 YR
Patient SexMale
-
-